Achieving consensus on quality indicators (QI) for pediatric Systemic Lupus Erythematosus (pSLE) by Pendl, Joshua et al.
POSTER PRESENTATION Open Access
Achieving consensus on quality indicators (QI) for
pediatric Systemic Lupus Erythematosus (pSLE)
Joshua Pendl
1*, Matt Hollander
2, Shannen Nelson
1, Wajeeha Yousaf
3, Nicola Ruperto
4, Michael Beresford
5,
Marisa Klein-Gitelman
6, Marilynn Punaro
7, Anne Stevens
2, Tadej Avcin
8, Graciela Espada
9, Tsz-Leung Lee
10,
Yu-Lung Lau
10, Jennifer Huggins
1, Esi Morgan-DeWitt
1, Hermine I Brunner
1
From 18th Pediatric Rheumatology European Society (PReS) Congress
Bruges, Belgium. 14-18 September 2011
Background
QI are retrospectively measurable elements of practice
performance for which there is evidence or consensus
that can be used to assess the quality of care provided.
Aim
To develop a set of consensus-derived QI for pSLE to
serve as international benchmarks for the quality of
patient care.
Methods
Based on the medical literature a Delphi survey was cre-
ated and distributed to the physician membership of
PRES, PANLAR, CARRA and the ACR via e-mail. Con-
sensus was considered 80% or higher.
Results
There was consensus (97%) among the 297 respondents
that simply applying QI developed by the ACR and
EULAR for adults with SLE (adult QI) was insufficient
and that distinct QI for pSLE were needed. Respondents
concurred that 5 of the 20 ACR and 6 of the 24 EULAR
adult QI are also suitable for pSLE. An additional 14
ACR and 13 EULAR adult QI might be useful for pSLE
after modifications. There was no consensus whether to
consider “Pregnancy” (45%) and “Reproductive Health”
(65%) as domains in the set of pSLE QI.
Conclusion
There is great demand among pediatric rheumatologists
to develop QI for pSLE. Initial agreement has been
reached about the types and domains of QI for pSLE,
but additional discussion and consensus formation
under consideration of the medical evidence is needed
to finalize a set of QI for pSLE that can be used to
define standard of care treatment for children and ado-
lescents with pSLE.
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